Recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) NCT06239272 Conditions Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more Locations Children's Healthcare of Atlanta — Atlanta, Georgia, United States Lurie Children's Hospital of Chicago — Chicago, Illinois, United States Our Lady of the Lake Children's Hospital — Baton Rouge, Louisiana, United States Dana Farber Cancer Institute — Boston, Massachusetts, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery NCT02180867 Conditions Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more Locations Children's Hospital of Alabama — Birmingham, Alabama, United States University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States The Kirklin Clinic at Acton Road — Birmingham, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States View all 381 locations View more locations Show fewer locations Loading locations... View Trial Details
